BLOOD BANKS' AUTOMATED TEST SYSTEMS FOR INFECTIOUS DISEASES SHOULD BE CONSIDERED CLASS II, BPAC RECOMMENDS; OTHER BLOOD COLLECTION DEVICES RECLASSIFIED
This article was originally published in The Gray Sheet
Executive Summary
Automated test systems used by blood banks for infectious disease screening should be regulated as Class II devices, FDA's Blood Products Advisory Committee recommended at a June 19 meeting in Rockville, Maryland.